These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10496323)

  • 1. Ly-49 receptor expression and functional analysis in multiple mouse strains.
    Ortaldo JR; Mason AT; Winkler-Pickett R; Raziuddin A; Murphy WJ; Mason LH
    J Leukoc Biol; 1999 Sep; 66(3):512-20. PubMed ID: 10496323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.
    Mason LH; Willette-Brown J; Mason AT; McVicar D; Ortaldo JR
    J Immunol; 2000 Jan; 164(2):603-11. PubMed ID: 10623801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
    Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
    Mason LH
    J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
    J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
    Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
    Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors.
    Ortaldo JR; Winkler-Pickett R; Wiegand G
    J Leukoc Biol; 2000 Nov; 68(5):748-56. PubMed ID: 11073116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
    Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
    Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
    Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
    J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d).
    Silver ET; Gong D; Hazes B; Kane KP
    J Immunol; 2001 Feb; 166(4):2333-41. PubMed ID: 11160290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras.
    Manilay JO; Waneck GL; Sykes M
    Int Immunol; 1998 Dec; 10(12):1943-55. PubMed ID: 9885916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2).
    Mason LH; Ortaldo JR; Young HA; Kumar V; Bennett M; Anderson SK
    J Exp Med; 1995 Aug; 182(2):293-303. PubMed ID: 7629495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
    Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
    J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.